Abstract:Imaging of apoptosis can allow noninvasive assessment of disease states and response to therapeutic intervention for a variety of diseases. The purpose of this study was to develop and evaluate a multimodal nanoplatform for the detection of apoptosis. Methods: To modulate the pharmacokinetics of annexin A5, a 36-kDa protein that binds specifically with phosphatidylserine, annexin A5 was conjugated to polyethylene glycol-coated, core-cross-linked polymeric micelles (CCPMs) dually labeled with near-infrared fluorescence fluorophores and a radioisotope (In-111). To evaluate the specificity of the binding of annexin A5-CCPM to apoptotic cells, both fluorescence microscopy and cell-binding studies were performed in vitro. Pharmacokinetics, biodistribution, dual nuclear and optical imaging, and immunohistochemical studies were performed in 2 xenografted tumor models to evaluate the potential applications of annexin A5-CCPM. Results: In cell-based studies, annexin A5-CCPM exhibited strongly specific binding to apoptotic tumor cells. This binding could be efficiently blocked by annexin A5. In mice, annexin A5-CCPM displayed a mean elimination half-life of 12.5 h. The mean initial concentration in blood was 22.4% of the injected dose/mL, and annexin A5-CCPM was mainly distributed in the central blood compartment. In mice bearing EL4 lymphoma treated with cyclophosphamide and etoposide and in mice bearing MDA-MB-468 breast tumors treated with poly(L-glutamic acid)-paclitaxel and cetuximab (IMC-C225) anti-epidermal growth factor receptor antibody, the tumor apoptosis was clearly visualized by both SPECT and fluorescence molecular tomography. In contrast, there was little accumulation of this nanoradiotracer in the tumors of untreated mice. The biodistribution data were consistent with the imaging data, with tumor-to-muscle and tumor-to-blood ratios of 38.8 and 4.1, respectively, in treated mice, and 14.8 and 2.2, respectively, in untreated mice bearing EL4 lymphoma. Moreover, further studies demonstrated that the conventional Tc-99m-labeled hydrazinonicotinamide annexin A5 and the plain CCPM control exhibited significantly lower uptake in the tumors of the treated mice than annexin A5-CCPM. Immunohistochemistry staining study showed that radioactivity count correlated with fluorescence signal from the nanoparticles, and both signals colocalized with the region of tumor apoptosis. Conclusion: Annexin A5-CCPM allowed visualization of tumor apoptosis by both nuclear and optical techniques. The complementary information acquired with multiple imaging techniques should be advantageous in assessing and validating early response to therapy.

An in vivo molecular imaging probe 18 F-Annexin B1 for apoptosis detection by PET/CT: preparation and preliminary evaluation

An in vivo molecular imaging probe 18F-Annexin B1 for apoptosis detection by PET/CT: preparation and preliminary evaluation

Preparation and bioevaluation of 99mTc-Annexin B1 as a novel radiotracer for apoptosis imaging

Preparation, in Vitro and in Vivo Evaluation of (99M)tc-Annexin B1: a Novel Radioligand for Apoptosis Imaging.

Experimental Study on Tumor Response to Chemotherapy with 18F-Sfb-annexin B1

Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.

Preparation and bioevaluation of 99m Tc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging

Evaluation of 18F-Sfb-annexin B1 in Detecting Apoptosis

Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, 18F labeled bis(zinc(II)-dipicolylamine) complex

Preparation and bioevaluation of 88Tcm-HYNIC-Annexin B1 as a novel radiotracer for apoptosis detection

SPECT and PET Radiopharmaceuticals for Molecular Imaging of Apoptosis: from Bench to Clinic

Annexin A5-functionalized nanoparticles for in vivo dual modality imaging of apoptosis

PET imaging of apoptosis in tumor-bearing mice and rabbits after paclitaxel treatment with (18)F(-)Labeled recombinant human His10-annexin V.

In Vivo Detection of Tumor Apoptosis Using a Novel PET/NIRF Imaging Probe: 18F-Psvue643

Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.

Combining [11C]-Anxa5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts

Longitudinal Pet Imaging of Doxorubicin Induced Apoptosis with F-18-Annexin V in A Xenografted Model

Advance in apoptosis imaging with annexins in tumor research

[ 18 F]-C-SNAT4: an improved caspase-3-sensitive nanoaggregation PET tracer for imaging of tumor responses to chemo- and immunotherapies

Apoptosis Imaging Probe Predicts Early Chemotherapy Response In Preclinical Models: A Comparative Study With F-18-Fdg Pet

Comparing 18F-Fdg Pet and 99Mtc-Labeled Ultrasmall Superparamagnetic Iron Oxide-Conjugated Annexin V Spect/Ct/Mr Imaging Apoptosis in Atherosclerotic Plaques